Kopra Bio
ActiveGenetically engineered viruses that teach your immune system to kill…
About
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
Founders · 1
Neurosurgery resident @ UCSF, scientific co-founder @ Kopra Bio. Published over 70 peer-reviewed publications as a neurosurgery resident at UCSF. Alex is particularly interested in the delivery of cell and gene therapies to the central nervous system and neuro-oncology. Kopra Bio is a serial biotech entrepreneur and a UCSF Neurosurgery resident on a mission to revolutionize cancer treatment.
Launch
Stealthy viruses that teach your immune system to kill cancer.
Kopra Bio presents a viral immunotherapy platform that uses stealthy viruses to infect cancer cells, prompt immune signaling, and recruit T cells to kill tumors. Targeting glioblastoma, they report preclinical survival gains above 90% and claim a scalable, cancer-selective approach with a broad platform applicability.
Formerly “GlioTx”
Related startups
Reprogramming Immunity for Target-Specific Medicines
A platform to make artificial viruses as cancer therapeutics.
